CN109464584A - 一种治疗哮喘中西药及制备方法 - Google Patents

一种治疗哮喘中西药及制备方法 Download PDF

Info

Publication number
CN109464584A
CN109464584A CN201811590232.1A CN201811590232A CN109464584A CN 109464584 A CN109464584 A CN 109464584A CN 201811590232 A CN201811590232 A CN 201811590232A CN 109464584 A CN109464584 A CN 109464584A
Authority
CN
China
Prior art keywords
chinese
western medicine
medicine
preparation
inophylline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811590232.1A
Other languages
English (en)
Inventor
张春
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201811590232.1A priority Critical patent/CN109464584A/zh
Publication of CN109464584A publication Critical patent/CN109464584A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8966Fritillaria, e.g. checker lily or mission bells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125Camphor; Nuclear substituted derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41661,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/064Saccharomycetales, e.g. baker's yeast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/17Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • A61K36/346Platycodon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605Morus (mulberry)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736Prunus, e.g. plum, cherry, peach, apricot or almond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明公开了一种治疗哮喘中西药及制备方法,各组分所占总重量百分比为:西药:甘草片0.10~0.60%、扑尔敏0.10~0.50%、安茶碱0.10~0.30%、新诺明0.05~0.25%、肺宝三效0.10~0.70%、强的松0.05~0.30%、酵母0.05~0.30%;中药:川贝母0.20~1.00%、桔梗0.10~0.80%、制麻黄0.10~0.40%、杏仁0.10~0.35%、桑白皮0.05~0.50%。本发明与现有技术相比的优点在于:具有治疗哮喘的功效,并具有健脾开胃合理联合用药比单用药物有优越性,既可降低药性提高疗效、减轻副作用,使药物发挥更大的疗效,因为是联合用药,所达到的治疗效果更加明显。

Description

一种治疗哮喘中西药及制备方法
技术领域
本发明涉及哮喘药领域,具体是指一种治疗哮喘中西药及制备方法。
背景技术
支气管由于环境的污染、气候变化异常、呼吸道疾病、接触物过敏、体质弱、免疫力低遗传等问题,现在医学目前尚无较好的预防及根治气管哮喘的药物,哮喘性支气管炎的病发率呈居高不下的状态,支气管炎是一个较顽固的病症,反复发作,今年我国中医在治疗支气管哮喘方面也进行大量工作,大多以中医制定为主尚未发现根治支气管哮喘病的药物。
发明内容
本发明要解决的技术问题是,针对以上问题提供一种能够有效预防及治疗支气管哮喘的药物。
为解决上述技术问题,本发明提供的技术方案为:一种治疗哮喘中西药及制备方法,各组分所占总重量百分比为:
西药:甘草片0.10~0.60%、扑尔敏0.10~0.50%、安茶碱0.10~0.30%、新诺明0.05~0.25%、肺宝三效0.10~0.70%、强的松0.05~0.30%、酵母0.05~0.30%;
中药:川贝母0.20~1.00%、桔梗0.10~0.80%、制麻黄0.10~0.40%、杏仁0.10~0.35%、桑白皮0.05~0.50%。
本发明与现有技术相比的优点在于:具有治疗哮喘的功效,并具有健脾开胃合理联合用药比单用药物有优越性,既可降低药性提高疗效、减轻副作用,使药物发挥更大的疗效,因为是联合用药,所达到的治疗效果更加明显。
作为改进,各组分所占总重量百分比为:
西药:甘草片0.20~0.58%、扑尔敏0.18~0.31%、安茶碱0.15~0.25%、新诺明0.12~0.20%、肺宝三效0.14~0.25%、强的松0.10~0.18%、酵母0.10~0.25%;
中药:川贝母0.30~0.75%、桔梗0.25~0.60%、制麻黄0.20~0.35%、杏仁0.15~0.30%、桑白皮0.15~0.40%。
作为改进,其制备方法为:
①按比例取西药:甘草片、扑尔敏、安茶碱、新诺明、肺宝三效和强的松精研成粉;
②加入酵母和适量的水进行发酵;
③按比例取中药:川贝母、桔梗、制麻黄、杏仁和桑白皮精研成粉后加入。
具体实施方式
本发明在具体实施时,一种治疗哮喘中西药及制备方法,各组分所占总重量百分比为:
西药:甘草片0.10~0.60%、扑尔敏0.10~0.50%、安茶碱0.10~0.30%、新诺明0.05~0.25%、肺宝三效0.10~0.70%、强的松0.05~0.30%、酵母0.05~0.30%;
中药:川贝母0.20~1.00%、桔梗0.10~0.80%、制麻黄0.10~0.40%、杏仁0.10~0.35%、桑白皮0.05~0.50%。
本发明与现有技术相比的优点在于:具有治疗哮喘的功效,并具有健脾开胃合理联合用药比单用药物有优越性,既可降低药性提高疗效、减轻副作用,使药物发挥更大的疗效,因为是联合用药,所达到的治疗效果更加明显。
作为改进,各组分所占总重量百分比为:
西药:甘草片0.20~0.58%、扑尔敏0.18~0.31%、安茶碱0.15~0.25%、新诺明0.12~0.20%、肺宝三效0.14~0.25%、强的松0.10~0.18%、酵母0.10~0.25%;
中药:川贝母0.30~0.75%、桔梗0.25~0.60%、制麻黄0.20~0.35%、杏仁0.15~0.30%、桑白皮0.15~0.40%。
作为改进,其制备方法为:
①按比例取西药:甘草片、扑尔敏、安茶碱、新诺明、肺宝三效和强的松精研成粉;
②加入酵母和适量的水进行发酵;
③按比例取中药:川贝母、桔梗、制麻黄、杏仁和桑白皮精研成粉后加入。
实施例:
实施例一:西药:甘草片0.20~0.58%、扑尔敏0.18~0.31%、安茶碱0.15~0.25%、新诺明0.12~0.20%、肺宝三效0.14~0.25%、强的松0.10~0.18%、酵母0.10~0.25%;
中药:川贝母0.30~0.75%、桔梗0.25~0.60%、制麻黄0.20~0.35%、杏仁0.15~0.30%、桑白皮0.15~0.40%。
①按比例取西药:甘草片、扑尔敏、安茶碱、新诺明、肺宝三效和强的松精研成粉;
②加入酵母和适量的水进行发酵;
③按比例取中药:川贝母、桔梗、制麻黄、杏仁和桑白皮精研成粉后加入。
实施例二:西药:甘草片0.25%、扑尔敏0.27%、安茶碱0.18%、新诺明0.16%、肺宝三效0.23%、强的松0.15%、酵母0.14%;
中药:川贝母0.62%、桔梗0.48%、制麻黄0.27%、杏仁0.19%、桑白皮0.20%。
①按比例取西药:甘草片、扑尔敏、安茶碱、新诺明、肺宝三效和强的松精研成粉;
②加入酵母和适量的水进行发酵;
③按比例取中药:川贝母、桔梗、制麻黄、杏仁和桑白皮精研成粉后加入。
混合服用,每次用药计量一2克为准,严重患者早晚各服一次,病情减轻晚服一次,直至痊愈,本发明还能够治疗感冒,对于各种疼痛都有缓解作用,利尿,对于呼吸道疾病和感冒效果极佳。
以上对本发明及其实施方式进行了描述,这种描述没有限制性,以上所示的也只是本发明的实施方式之一,实际的结构并不局限于此。总而言之如果本领域的普通技术人员受其启示,在不脱离本发明创造宗旨的情况下,不经创造性的设计出与该技术方案相似的结构方式及实施例,均应属于本发明的保护范围。

Claims (3)

1.一种治疗哮喘中西药及制备方法,其特征在于:各组分所占总重量百分比为:
西药:甘草片0.10~0.60%、扑尔敏0.10~0.50%、安茶碱0.10~0.30%、新诺明0.05~0.25%、肺宝三效0.10~0.70%、强的松0.05~0.30%、酵母0.05~0.30%;
中药:川贝母0.20~1.00%、桔梗0.10~0.80%、制麻黄0.10~0.40%、杏仁0.10~0.35%、桑白皮0.05~0.50%。
2.根据权利要求1所述的一种治疗哮喘中西药,其特征在于:各组分所占总重量百分比为:
西药:甘草片0.20~0.58%、扑尔敏0.18~0.31%、安茶碱0.15~0.25%、新诺明0.12~0.20%、肺宝三效0.14~0.25%、强的松0.10~0.18%、酵母0.10~0.25%;
中药:川贝母0.30~0.75%、桔梗0.25~0.60%、制麻黄0.20~0.35%、杏仁0.15~0.30%、桑白皮0.15~0.40%。
3.根据权利要求1所述的一种治疗哮喘中西药及制备方法,其制备方法为:
①按比例取西药:甘草片、扑尔敏、安茶碱、新诺明、肺宝三效和强的松精研成粉;
②加入酵母和适量的水进行发酵;
③按比例取中药:川贝母、桔梗、制麻黄、杏仁和桑白皮精研成粉后加入。
CN201811590232.1A 2018-12-25 2018-12-25 一种治疗哮喘中西药及制备方法 Pending CN109464584A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811590232.1A CN109464584A (zh) 2018-12-25 2018-12-25 一种治疗哮喘中西药及制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811590232.1A CN109464584A (zh) 2018-12-25 2018-12-25 一种治疗哮喘中西药及制备方法

Publications (1)

Publication Number Publication Date
CN109464584A true CN109464584A (zh) 2019-03-15

Family

ID=65677257

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811590232.1A Pending CN109464584A (zh) 2018-12-25 2018-12-25 一种治疗哮喘中西药及制备方法

Country Status (1)

Country Link
CN (1) CN109464584A (zh)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1179976A (zh) * 1997-10-12 1998-04-29 殷清成 根治呼吸系统疾病的化痰平喘净
CN1256942A (zh) * 1999-11-10 2000-06-21 王守东 一种治疗咳喘的药物组合物及其制备方法
CN1333054A (zh) * 2000-12-26 2002-01-30 高守荣 止咳平喘药剂
CN1562317A (zh) * 2004-04-19 2005-01-12 李文章 一种止咳平喘的药物
CN107669936A (zh) * 2017-11-20 2018-02-09 北京煜煌科技有限公司 一种儿科治疗哮喘的药物及其制备方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1179976A (zh) * 1997-10-12 1998-04-29 殷清成 根治呼吸系统疾病的化痰平喘净
CN1256942A (zh) * 1999-11-10 2000-06-21 王守东 一种治疗咳喘的药物组合物及其制备方法
CN1333054A (zh) * 2000-12-26 2002-01-30 高守荣 止咳平喘药剂
CN1562317A (zh) * 2004-04-19 2005-01-12 李文章 一种止咳平喘的药物
CN107669936A (zh) * 2017-11-20 2018-02-09 北京煜煌科技有限公司 一种儿科治疗哮喘的药物及其制备方法

Similar Documents

Publication Publication Date Title
CN102488882B (zh) 一种治疗猪呼吸道疾病综合征的复方蜂胶组合物及其制备方法
CN103638488B (zh) 一种治疗胸膜炎的中药组合物
CN103845407A (zh) 一种治疗乳糜胸的中药
CN104306793B (zh) 一种治疗大叶性肺炎的中药制剂
CN109464584A (zh) 一种治疗哮喘中西药及制备方法
CN103933437A (zh) 一种治疗哮喘的中药组合物及其制备方法
CN107823600A (zh) 治疗小儿寒性咳嗽的中药制剂
CN103463517B (zh) 治疗哮喘的药物
CN102961630B (zh) 一种利用鸡肫草治疗支气管炎的中药
CN102961570B (zh) 一种治疗风热犯肺型支气管炎的中药
CN104998080A (zh) 一种用于治疗咳嗽变异性哮喘的中药组合物
CN105641377A (zh) 治疗猪支气管肺炎的中药煎煮液及其制备方法
CN110064033A (zh) 一种止咳化痰凝血的药物组合物及其制备方法
CN109674847A (zh) 一种用于治疗咳喘的雾化药物组合物及其制备方法
CN103463518B (zh) 一种止咳平喘的药物
CN102430115B (zh) 一种治疗猪圆环病毒病的复方蜂胶组合物及其制备方法
CN103223157B (zh) 一种用于治疗感冒的中药组合物
CN105362548A (zh) 一种治疗过敏性哮喘的中药
CN103751743A (zh) 一种治疗慢性阻塞性肺病的中药丸及其制作方法
CN105816836A (zh) 一种治疗间质性肺炎的中药制剂及其应用
CN105797096A (zh) 一种穴位咳喘贴
CN104258361A (zh) 一种治疗小儿哮喘的中药组合物
CN104161835A (zh) 一种治疗痰热咳嗽的中药
CN104398941A (zh) 一种用于治疗长期干咳的中药组合物
CN103638433B (zh) 一种治疗胸膜炎的纯中药组合物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190315

RJ01 Rejection of invention patent application after publication